Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
Apellis Pharmaceuticals (Nasdaq: APLS) has announced its participation in the UBS Virtual Ophthalmology Day. The company will host a fireside chat on Wednesday, October 2, 2024, at 8:30 a.m. ET. This event will be accessible through a live webcast on the company's website, specifically on the "Events and Presentations" page within the "Investors and Media" section.
For those unable to attend the live event, Apellis will provide a replay of the webcast, which will remain available for approximately 90 days following the event. This virtual participation underscores Apellis' commitment to engaging with investors and industry professionals in the ophthalmology sector.
Apellis Pharmaceuticals (Nasdaq: APLS) ha annunciato la sua partecipazione al UBS Virtual Ophthalmology Day. L'azienda ospiterà una conversazione intima mercoledì, 2 ottobre 2024, alle 8:30 ET. Questo evento sarà accessibile tramite un webcast dal vivo sul sito web dell'azienda, specificamente nella pagina dedicata agli Eventi e Presentazioni nella sezione Investitori e Media.
Per coloro che non possono partecipare all'evento dal vivo, Apellis fornirà una registrazione del webcast, che rimarrà disponibile per circa 90 giorni successivi all'evento. Questa partecipazione virtuale sottolinea l'impegno di Apellis nel coinvolgere investitori e professionisti del settore oftalmologico.
Apellis Pharmaceuticals (Nasdaq: APLS) ha anunciado su participación en el Día Virtual de Oftalmología de UBS. La compañía llevará a cabo una charla informal el miércoles, 2 de octubre de 2024, a las 8:30 a.m. ET. Este evento será accesible a través de un webcast en vivo en el sitio web de la compañía, específicamente en la página de Eventos y Presentaciones dentro de la sección Inversionistas y Medios.
Para aquellos que no puedan asistir al evento en vivo, Apellis proporcionará una retransmisión del webcast, que estará disponible durante aproximadamente 90 días después del evento. Esta participación virtual resalta el compromiso de Apellis de conectarse con inversores y profesionales de la industria en el sector de la oftalmología.
Apellis Pharmaceuticals (Nasdaq: APLS)는 UBS 가상 안과의 날에 참여한다고 발표했습니다. 회사는 2024년 10월 2일 수요일 오전 8시 30분 ET에 화상 대화를 주최할 예정입니다. 이 이벤트는 회사 웹사이트의 투자자 및 언론 섹션 내 행사 및 발표 페이지를 통해 생중계로 접근할 수 있습니다.
실시간 이벤트에 참석할 수 없는 분들을 위해 Apellis는 이벤트 이후 약 90일 동안 이용 가능한 웹캐스트 재방송을 제공합니다. 이 가상 참여는 안과 분야의 투자자 및 업계 전문가와 소통하려는 Apellis의 의지를 강조합니다.
Apellis Pharmaceuticals (Nasdaq: APLS) a annoncé sa participation au Journée d'Oftalmologie Virtuelle de UBS. L'entreprise organisera une discussion informelle le mercredi 2 octobre 2024, à 8h30 ET. Cet événement sera accessible via un webcast en direct sur le site web de l'entreprise, plus précisément sur la page Événements et Présentations au sein de la section Investisseurs et Médias.
Pour ceux qui ne peuvent pas assister à l'événement en direct, Apellis proposera une rediffusion du webcast, qui sera disponible pendant environ 90 jours après l'événement. Cette participation virtuelle souligne l'engagement d'Apellis à dialoguer avec les investisseurs et les professionnels de l'industrie ophtalmologique.
Apellis Pharmaceuticals (Nasdaq: APLS) hat seine Teilnahme am UBS Virtuellen Augenheiltag bekannt gegeben. Das Unternehmen wird am Mittwoch, den 2. Oktober 2024, um 8:30 Uhr ET einen Feuerplatz-Dialog ausrichten. Diese Veranstaltung wird über ein Live-Webcast auf der Unternehmenswebsite zugänglich sein, speziell auf der Seite Veranstaltungen und Präsentationen in der Sektion Investoren und Medien.
Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird Apellis eine Wiedergabe des Webcasts bereitstellen, die für ungefähr 90 Tage nach der Veranstaltung verfügbar bleibt. Diese virtuelle Teilnahme unterstreicht Apellis' Engagement, mit Investoren und Fachleuten der Augenheilkunde in Kontakt zu treten.
- None.
- None.
WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the UBS Virtual Ophthalmology Day on Wednesday, October 2, 2024, at 8:30 a.m. ET.
The live event webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.
Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178
FAQ
When is Apellis Pharmaceuticals (APLS) participating in the UBS Virtual Ophthalmology Day?
What type of event is Apellis Pharmaceuticals (APLS) hosting at the UBS Virtual Ophthalmology Day?
How can investors access Apellis Pharmaceuticals' (APLS) fireside chat at the UBS Virtual Ophthalmology Day?
How long will the replay of Apellis Pharmaceuticals' (APLS) UBS Virtual Ophthalmology Day fireside chat be available?
